STOCK TITAN

Everest Group, Ltd. (EG) 10-Q Filings

EG NYSE

Here are the 10-Q quarterly reports from Everest Group, Ltd. (EG) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow EG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EG filings page.

Rhea-AI Summary

Everest Group, Ltd. (EG) reported third-quarter 2026 net income of $233 million, compared with $255 million a year earlier; nine-month net income was $1.445 billion, up from $1.145 billion. Nine-month total revenue was $11.742 billion versus $13.073 billion, as earned premiums declined to $10.220 billion from $11.698 billion, while net investment income rose to $1.725 billion from $1.563 billion.

Third-quarter comprehensive loss was $649 million, compared with comprehensive income of $422 million a year earlier; net-of-tax other comprehensive loss was $882 million, including $935 million of unrealized depreciation of securities. Nine-month operating cash flow was $1.606 billion, versus $3.466 billion.

The State National adverse-development treaty covers $1.3 billion of carried reserves and potential additional adverse development up to $600 million; the MS Transverse treaty has an aggregate limit of $400 million after a $122 million premium payment, recognized as a 2025 pre-tax loss. Everest completed the Canadian commercial retail insurance sale on October 1, 2026; the Colombia sale was anticipated for the fourth quarter of 2026 and the Mexico sale for 2027.

Rhea-AI Summary

Everest Group, Ltd. reported Q2 2026 premiums earned of $3,490 million and total revenues of $3,961 million, generating net income of $559 million. For the first six months of 2026, premiums earned were $7,064 million and net income was $1,213 million versus $890 million a year earlier, with underwriting gain of $597 million. Total assets were $62,167 million and shareholders’ equity $15,430 million as of June 30, 2026.

The company is reshaping its portfolio, emphasizing Reinsurance Treaty and Global Wholesale & Specialty while moving most commercial retail operations into its Legacy segment. It agreed to sell Canadian commercial retail operations to Wawanesa for C$410 million and Colombian operations to AIG, and reported related assets of $247 million as held-for-sale. Adverse development reinsurance with State National and MS Transverse provides up to $600 million and $400 million of protection, respectively, on $5.4 billion of prior-year reserves, with $1.26 billion ceded to State National by June 30, 2026. Net cash from operating activities for the half-year was $939 million; the company paid $158 million in dividends and spent $725 million on treasury share purchases.

Rhea-AI Summary

Everest Group, Ltd. reported much higher profitability for the three months ended March 31, 2026. Net income rose to $653 million on total revenues of $4.07 billion, compared with $210 million on $4.26 billion a year earlier, as incurred losses and loss adjustment expenses dropped to $2.22 billion from $2.89 billion. Net investment income increased to $567 million, while catastrophe losses declined to $130 million from $534 million, easing pressure on underwriting results.

The company is reshaping its portfolio. It sold renewal rights for significant commercial retail insurance lines to AIG in 2025, recording sizeable gains and ongoing transition costs, and agreed to sell its Canadian Commercial Retail Insurance operations to Wawanesa for C$410 million, subject to regulatory approvals. Everest also entered adverse development reinsurance agreements effective October 1, 2025 to reinsure up to $1.0 billion of potential adverse loss development on prior accident years, helping manage long-tail legacy exposures.

Rhea-AI Summary

Everest Group (EG) filed its Q3 2025 report, showing steady top-line but lower profitability. Total revenues were $4.32 billion, up slightly from $4.29 billion a year ago, while net income fell to $255 million from $509 million as incurred losses and expenses rose. Diluted EPS was $6.09 versus $11.80.

For the first nine months, revenues reached $13.07 billion and net income was $1.15 billion, compared with $12.65 billion and $1.97 billion in the prior-year period. Net investment income increased to $540 million in the quarter and $1.56 billion year‑to‑date. The company declared dividends of $2.00 per share in Q3 and $6.00 per share year‑to‑date 2025.

The balance sheet expanded: total assets were $62.24 billion and shareholders’ equity rose to $15.38 billion, supported by a sharp improvement in accumulated other comprehensive income to $(154) million from $(1.14) billion at year‑end. Investments and cash totaled $45.83 billion. Shares outstanding were 41,978,058 as of October 24, 2025.